RE: Celebrate sng success20 Jan 2021 20:13
Har - P3 is still very, very risky. It's not so much the wait, as the associated risk.
It makes no sense to be out if this one for the next 2 months, as P3 won't be in yet, but there are possibilities of EUA, II accumulation or T/O on the back of home trial, P3 interims, Activ-2, etc. Unless there's a cheeky placing hanging over us to fund more trials or production (an unlikely event in my view), I consider the next 2 months a free-ride.